Health Care

Most Active Stock: MannKind Corp. (MNKD)

Most Active Stock: MannKind Corp. (MNKD)”

Professional analysts at H.C. Wainwright has a key "Buy" rating for MannKind (NASDAQ:MNKD). As per Friday, August 11, the company rating was maintained by Maxim Group. Equity analyst Maxim Group began coverage of the stock with a rating of "Buy".

Recent action on shares of MannKind Corporation (NASDAQ:MNKD) lands the stock on today's most volatile list.

Shares of Mannkind Corporation (NASDAQ:MNKD) now have an Average Brokerage Recommendation of 3, number of Recs in ABR is 2 while industry rank of the company by ABR is 155 out of 265.

Among 7 analysts covering Mannkind (NASDAQ:MNKD), 3 have Buy rating, 3 Sell and 1 Hold. The company now has a consensus rating of "Hold" and an average target price of $0.92.

Investors wait MannKind Corporation (NASDAQ:MNKD) to report on November, 8. its quarterly earnings Wall Street analysts expect $-0.28 earnings per share, down $1.58 or 121.54 % from last year's $1.3 same quarter earnings. Taking the time to properly examine a company before purchasing shares may be the difference between healthy profits and disappointing losses. Analysts reported that the Price Target for MannKind Corp. might touch $7 high while the Average Price Target and Low price Target is $7 and $7 respectively. The company's 50 day moving average price is $2.43 and its 200-day moving average price is $1.58. The total amount of shares outstanding is 1.93B, giving the company a market capitalization of about 125.34B.

MannKind Corporation (MNKD) revenue totaled $2 million down -33.55% from the previous quarter. Next quarter's EPS is estimated at $-0.21 with next year's EPS projected to be $-0.84. MannKind intends to use the net proceeds from the offering for working capital and general corporate purposes.

MannKind Corporation (NASDAQ:MNKD) recorded a trading volume of 48.04 million shares, above its 90-day volume average of 4.99 million shares. If you are accessing this report on another site, it was stolen and republished in violation of United States & worldwide copyright & trademark law. The firm initiated coverage in a research report revealed to clients and investors on Tuesday morning.

Investors are a little more bearish on shares of the company recently looking at the change in short interest.

Harel Insurance Investments & Financial Services Ltd. trimmed its ownership by shedding 2,460,000 shares a decrease of 83.4% in the quarter. After having $-0.35 EPS previously, MannKind Corporation's analysts see -20.00 % EPS growth. Harel Insurance Investments & Financial Services Ltd. now owns 588,520 shares of the biopharmaceutical company's stock worth $830,000 after acquiring an additional 98,520 shares in the last quarter.

MannKind Corporation (MNKD) has made its way to a 12-month gain of 110.41%. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The Company's product candidate is AFREZZA, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and helps in glycemic control.



Like this

Latest


12 October 2017
Man Utd boss Mourinho: Salah Liverpool success no surprise for me
And the Portuguese will no doubt be furious with Belgium boss Roberto Martinez for risking Fellaini, with the country already having qualified for the World Cup.

12 October 2017
Russia Strongly Opposes Russian Flag Removal From Closed San Francisco Consulate
However, the lawmaker said it was early to speak about any particular plans on preparing such an initiative. The Russian embassy and US State Department were not immediately available for comment.

12 October 2017
Supremo retoma análise da ação sobre afastamento de parlamentares
Para ele, ao determinar o recolhimento domiciliar à noite, o STF apenas impede que o senador frequente "baladas e restaurantes". Para o ministro, as medidas cautelares devem ser permitidas em casos excepcionais, mas podem ser revistas pelo Legislativo.

12 October 2017
0.94 is Newell Rubbermaid Inc's (NYSE:NWL) Institutional Investor Sentiment
Following the transaction, the director now directly owns 87,883 shares in the company, valued at approximately $3,831,698.80. Out of 17 Wall Street analysts rating Newell Rubbermaid Inc ., 13 give it "Buy", 0 "Sell" rating, while 4 recommend "Hold".

12 October 2017
Walt Disney Company (The) (DIS) Stake Increased by CIBC Asset Management Inc
After $1.58 actual EPS reported by Walt Disney Co for the previous quarter, Wall Street now forecasts -23.42% negative EPS growth. It increased, as 77 investors sold DIS shares while 606 reduced holdings. 108 funds opened positions while 638 raised stakes.

12 October 2017
'Many' Fed members favor December rate hike: minutes
That view gained further credence in the wake of strong US economic data and Fed officials' comments. Another group suggested that no further rate increases were called for in the near term.

12 October 2017
Duterte to police: Leave drug campaign to anti-narcotics agency
The PNP chief apologized has already apologized for the remark as it was only a "spur of the moment reaction". NBI is the National Bureau of Investigation while PDEA is the Philippine Drug Enforcement Agency.

12 October 2017
Stephen King's 'The Talisman' Movie Taps Writer Josh Boone
Stay tuned to Heroic Hollywood for the latest news on Boone's feature film adaptation of King's The Talisman as we learn it. That adaptation is now in development.

12 October 2017
Investment Research Analysts Opinion: BlackBerry Limited (BBRY), Fibria Celulose SA (FBR)
TRADEMARK VIOLATION WARNING: This report was first posted by TrueBlueTribune and is the property of of TrueBlueTribune. Keeping an eyeball on Moving Averages, the 50-day is 9.5737; the 200-day is at 9.5782, for BlackBerry Limited (BBRY ).

12 October 2017
Catalonia: Madrid asks the Catalan president to "say if he declared independence"
Addressing parliament later, Mr Rajoy said Spanish democracy was "experiencing one of the most serious moments in its history". I don't think that in the short term something will happen".



Recommended